Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Daenthanasanmak A, Bamford RN, Yoshioka M, Yang SM, Homan P, Karim B, Bryant BR, Petrus MN, Thomas CJ, Green PL, Miljkovic MD, Conlon KC, Waldmann TA.
Daenthanasanmak A, et al. Among authors: miljkovic md.
Blood Adv. 2022 Apr 12;6(7):2346-2360. doi: 10.1182/bloodadvances.2021005948.
Blood Adv. 2022.
PMID: 35030628
Free PMC article.